UPODS

uPODS is a biotechnology company focused on the intracellular delivery of functional protein therapeutics. Based on technology developed at the University of Pennsylvania, the company's Universal Protein-Only Delivery System (uPODS) platform uses self-assembling protein tags to transport biologics across the cell membrane. This approach allows for the direct cytosolic delivery of antibodies, enzymes, and other proteins without the need for chemical conjugation or lipid nanoparticles. By accessing the 'undruggable' intracellular space, uPODS aims to develop new treatments for oncology and rare genetic disorders. The company is currently in the pre-clinical stage, advancing its platform toward therapeutic applications.